Merck to Cut Price of HIV Drug in Poor Countries
Drug giant Merck & Co said on Wednesday it will cut the price of its AIDS drug Stocrin to below $1 per day in poor countries hit hardest by the epidemic.
(
Reuters,
10/23/2002 08:36 AM PDT)
STI and SIT Treatments for HIV: Are They for You?
This video webcast discusses the new philosophy of treating HIV and AIDS: SIT and STI.
(
David R. Marks, MD, WNBC, New York,
Larry Higgins, DO, MPH; Mt. Sinai School of Medicine-Private Practice, NY Brian A. Boyle, MD; Weill Cornell Medical School-New York Presbyterian Hospital,
10/22/2002 11:55 AM PDT)
Inexpensive Test Predicts AIDS Progression
A relatively inexpensive test is as effective as currently used tests for predicting how soon a person infected with HIV will progress to full-blown AIDS, according to the results of a new study.
(
BY MERRITT MCKINNEY,
Reuters,
10/21/2002 12:12 PM PDT)
World Bank Commits $1 Billion to Fight Africa AIDS
The World Bank has committed $1 billion to fight HIV/AIDS in Africa and much of the support will be in the form of grants, the bank's Vice President for Africa Callisto Madavo said Sunday.
(
BY MANOAH ESIPISU,
Reuters,
10/21/2002 12:12 PM PDT)
HIV+ in Nursing Homes Not Getting Psychiatric Help
HIV+ patients in nursing homes who have been diagnosed with depression may not be getting the mental health help they need, a new report suggests. Only 60% of such patients are receiving daily antidepressants, and fewer than half are getting other types of mental healthcare, such as therapy, according to Dr. Robert J. Buchanan of Texas A&M University in College Station, and colleagues.
(
BY FAITH REIDENBACH,
Reuters,
10/21/2002 07:12 AM PDT)
South Africa seen joining mainstream on AIDS treatment
South Africa may be finally joining the global mainstream on the treatment of AIDS, including use of the antiretroviral drugs it has so far repudiated.
(
BY BRENDAN BOYLE,
Reuters,
10/14/2002 11:08 AM PDT)
Study targets an HIV mystery
Researchers at the University of Minnesota may have unlocked another key mystery surrounding HIV, the virus that causes AIDS. The discovery, which has to be confirmed by a larger study, appears to explain why a quarter of the patients infected with the AIDS virus respond poorly to the powerful drug cocktails while the others show dramatic improvements.
(
BY TOM MAJESKI,
Pioneer Press,
10/10/2002 07:29 AM PDT)
DNA analysis cracks HIV attempted murder case
Researchers reported on Monday the details of a genetic analysis used to identify a woman's particular strain of HIV, thereby helping to convict her former boyfriend on charges of attempted murder.
(
BY ALISON MCCOOK,
Reuters,
10/08/2002 07:40 AM PDT)
Bicyclist organizes his own AIDS ride
Stephen Parish had his bags packed and bike tuned to participate in a 500-mile trek across Europe in support of AIDS research last year.
(
BY MELINDA ROGERS,
Pioneer Press,
10/04/2002 07:56 AM PDT)
Antibody region that blocks HIV identified
New research on people who remain uninfected with HIV despite repeated exposures has identified the region on an antibody in their immune system that blocks infection by binding to the virus and neutralizing it.
(
BY DANA FRISCH,
Reuters,
10/04/2002 07:31 AM PDT)
|